Indication
Mucopolysaccharidosis type IV-A
Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, autosomal recessive lysosomal storage disease caused by pathogenic variants in the *GALNS* gene. Read more about Mucopolysaccharidosis type IV-A
1 drugs 1 manufacturers
Drugs that treat it
Common Mucopolysaccharidosis type IV-A therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, autosomal recessive lysosomal storage disease caused by pathogenic variants in the *GALNS* gene.
This genetic defect results in a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase, leading to the progressive accumulation of the glycosaminoglycans keratan sulfate and chondroitin-6-sulfate predominantly in bone, cartilage, and connective tissues.
The condition primarily impacts the pediatric-onset skeletal system and manifests as severe systemic skeletal dysplasia, including marked short stature with a disproportionately short trunk, kyphoscoliosis, chest deformities, joint hypermobility, and life-threatening atlantoaxial instability with cervical myelopathy.
Additional non-skeletal complications often involve corneal clouding, sensorineural or conductive hearing loss, restrictive pulmonary disease, and cardiac valve dysfunction, typically in the absence of primary cognitive impairment.
- nih.gov
Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, autosomal recessive lysosomal storage disease caused by pathogenic variants in the *GALNS* gene This genetic defect results in a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase, leading to the progressive accumulation of the glycosaminoglycans keratan sulfate and chondroitin-6-sulfate predominantly in bone, cartilage, and connective tissues
- medlineplus.gov
Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, autosomal recessive lysosomal storage disease caused by pathogenic variants in the *GALNS* gene The condition primarily impacts the pediatric-onset skeletal system and manifests as severe systemic skeletal dysplasia, including marked short stature with a disproportionately short trunk, kyphoscoliosis, chest deformities, joint hypermobility, and life-threatening atlantoaxial instability with cervical myelopathy Addition...
- nih.gov
Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, autosomal recessive lysosomal storage disease caused by pathogenic variants in the *GALNS* gene This genetic defect results in a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase, leading to the progressive accumulation of the glycosaminoglycans keratan sulfate and chondroitin-6-sulfate predominantly in bone, cartilage, and connective tissues
- medlineplus.gov
The condition primarily impacts the pediatric-onset skeletal system and manifests as severe systemic skeletal dysplasia, including marked short stature with a disproportionately short trunk, kyphoscoliosis, chest deformities, joint hypermobility, and life-threatening atlantoaxial instability with cervical myelopathy Additional non-skeletal complications often involve corneal clouding, sensorineural or conductive hearing loss, restrictive pulmonary disease, and cardiac valve dysfunction, typicall...
- rarediseases.org
The condition primarily impacts the pediatric-onset skeletal system and manifests as severe systemic skeletal dysplasia, including marked short stature with a disproportionately short trunk, kyphoscoliosis, chest deformities, joint hypermobility, and life-threatening atlantoaxial instability with cervical myelopathy Additional non-skeletal complications often involve corneal clouding, sensorineural or conductive hearing loss, restrictive pulmonary disease, and cardiac valve dysfunction, typicall...
Personalize your experience
Follow Mucopolysaccharidosis type IV-A and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.